Aspartate-444 is essential for productive substrate interactions in a neuronal glutamate transporter.
In the central nervous system, electrogenic sodium- and potassium-coupled glutamate transporters terminate the synaptic actions of this neurotransmitter. In contrast to acidic amino acids, dicarboxylic acids are not recognized by glutamate transporters, but the related bacterial DctA transporters are capable of transporting succinate and other dicarboxylic acids. Transmembrane domain 8 contains several residues that differ between these two types of transporters. One of these, aspartate-444 of the neuronal glutamate transporter EAAC1, is conserved in glutamate transporters, but a serine residue occupies this position in DctA transporters. When aspartate-444 is mutated to serine, cysteine, alanine, or even to glutamate, uptake of D-[(3)H]-aspartate as well as the inwardly rectifying steady-state currents induced by acidic amino acids is impaired. Even though succinate was not capable of inducing any steady-state transport currents, the dicarboxylic acid inhibited the sodium-dependent transient currents by the mutants with a neutral substitution at position 444. In the neutral substitution mutants inhibition of the transients was also observed with acidic amino acids. In the D444E mutant, acidic amino acids were potent inhibitors of the transient currents, whereas the apparent affinity for succinate was lower by at least three orders of magnitude. Even though L-aspartate could bind to D444E with a high apparent affinity, this binding resulted in inhibition rather than stimulation of the uncoupled anion conductance. Thus, a carboxylic acid-containing side chain at position 444 prevents the interaction of glutamate transporters with succinate, and the presence of aspartate itself at this position is crucial for productive substrate binding compatible with substrate translocation.
Teichman
Shlomit
S
Department of Biochemistry, Hebrew University Hadassah Medical School, Jerusalem 91120, Israel.
Kanner
Baruch I
BI
D000409:Alanine / Q000737:chemistry; D000818:Animals; D001224:Aspartic Acid / Q000737:chemistry* / Q000378:metabolism; D001665:Binding Sites; D003545:Cysteine / Q000737:chemistry; D029382:Dicarboxylic Acid Transporters / Q000737:chemistry / Q000378:metabolism*; D050580:Excitatory Amino Acid Transporter 3 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D018698:Glutamic Acid / Q000737:chemistry / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D008845:Microinjections; D009154:Mutation; D009474:Neurons / Q000378:metabolism*; D009865:Oocytes; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D011817:Rabbits; D012694:Serine / Q000737:chemistry; D019802:Succinic Acid / Q000378:metabolism*; D014162:Transfection; D014982:Xenopus laevis
D029382:Dicarboxylic Acid Transporters; D050580:Excitatory Amino Acid Transporter 3; D001224:Aspartic Acid; D018698:Glutamic Acid; D012694:Serine; D019802:Succinic Acid; D003545:Cysteine; D000409:Alanine